RhumbLine Advisers’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89K | Sell |
2,581
-111,877
| -98% | -$82K | ﹤0.01% | 4001 |
|
|
2025
Q1 | $114K | Buy |
114,458
+1,718
| +2% | +$1.72K | ﹤0.01% | 3344 |
|
|
2024
Q4 | $1.2M | Buy |
112,740
+1,075
| +1% | +$11.4K | ﹤0.01% | 2155 |
|
|
2024
Q3 | $1.48M | Buy |
111,665
+8,407
| +8% | +$111K | ﹤0.01% | 2059 |
|
|
2024
Q2 | $1.02M | Buy |
103,258
+85,706
| +488% | +$842K | ﹤0.01% | 2236 |
|
|
2024
Q1 | $241K | Buy |
17,552
+1,832
| +12% | +$25.2K | ﹤0.01% | 3087 |
|
|
2023
Q4 | $268K | Buy |
+15,720
| New | +$268K | ﹤0.01% | 3036 |
|